Emergent BioSolutions (EBS) Shares Outstanding (Weighted Average) (2010 - 2026)

Emergent BioSolutions' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $51.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 4.6% year-over-year to $51.9 million; the TTM figure through Mar 2026 stood at $51.9 million (down 4.6% YoY), while the FY2025 annual figure was $53.5 million, up 0.94% from the prior year.
• Shares Outstanding (Weighted Average) was $51.9 million for Q1 2026 at Emergent BioSolutions, down from $53.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $54.4 million in Q1 2025 to a low of $50.0 million in Q2 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $52.0 million across 5 years, with a median of $51.9 million in 2026.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) dropped 6.72% in 2022, then advanced 4.21% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $50.1 million in 2022, then gained by 2.2% to $51.2 million in 2023, then grew by 3.52% to $53.0 million in 2024, then increased by 0.94% to $53.5 million in 2025, then decreased by 2.99% to $51.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $51.9 million (Q1 2026), $53.5 million (Q4 2025), and $53.9 million (Q3 2025), per Business Quant data.